JONBUR Research · Initiation
Daechang · 012800 · Steel & Materials
Daechang: Thin Margins and Low Multiples Alongside a Wide Valuation Model Range
Why this report
Start of coverage: written when a reader opened this company and there was no report yet.
Daechang's shares closed at ₩1,024 on 2026-10-23, down 21.5% over one year and near the low end of a 52-week range of ₩950 to ₩2,095. Trailing revenue reached ₩1.69T with a 5.0% operating margin, but net margin is only 1.3% and free cash flow is negative.
Written Oct 24, 2026 · Data as of Oct 23, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
Thesis
The data supports a picture of recovering operations: operating income moved from a ₩9.3B loss in 2023 to ₩84.0B over the trailing twelve months to H1 2026. Revenue has also grown, from ₩1.32T in 2023 to ₩1.69T on a trailing basis.
What the data does not support is a clean earnings story. Net income is small relative to operating income (₩22.6B versus ₩84.0B), liabilities are about 199.7% of equity, and trailing free cash flow is negative at ₩19.5B. The share price has fallen 12.2% in the last month, and no news headlines are available to explain the move.
The low multiples (P/E 4.1, P/B 0.3) sit alongside a history of volatile profits, so they may reflect how the market views earnings durability rather than a simple gap in price.
Business overview
Daechang is listed on KOSPI in the Steel & Materials sector. It was founded on 1977-12-19 and listed on 1989-12-05. The data shows 91,140,499 listed shares and a market capitalisation of about ₩93.3B. Co-CEOs are listed as 조시영 and 조정호, and a change of representative director was filed on 2026-03-26. Annual revenue has ranged from ₩1.28T in 2021 to ₩1.47T in 2025. Product lines and segment detail are not available in the data.
Financial analysis
The figures below come from filed financial statements. Revenue was ₩1.47T in 2025, up 10.0%, after growth of 1.0% in 2024 and a decline of 8.2% in 2023. Operating margin improved from -0.7% in 2023 to 2.3% in 2024 and 3.5% in 2025, and was 5.0% on a trailing basis to H1 2026.
Net income was ₩2.1B in 2025 (ROE 0.8%) and ₩22.6B on a trailing basis (net margin 1.3%, ROE 7.6%). The best year shown is 2021, with net income of ₩26.0B and ROE of 10.7%.
Cash was ₩58.5B against borrowings of ₩97.0B. Liabilities to equity were 199.7%. Trailing free cash flow was -₩19.5B. Dividend yield is shown as 0.0%.
Valuation
Current multiples are P/E 4.1, P/B 0.3 and P/S 0.1. Enterprise value is ₩131.8B, and EV/EBITDA is not available. Year-end P/B has been 0.4 to 0.7 over 2021 to 2025, so the current 0.3 is below its own history. Year-end P/E was 6.4 in 2021 and much higher in later years because profits were small.
Among the listed peers, P/E ranges from 8.3 (Poongsan) to 18.1 (Korea Zinc) and P/B from 0.2 (Hyundai Steel) to 1.6 (Korea Zinc). Daechang's P/E is below all peers with a figure, and its P/B is below all except Hyundai Steel.
The valuation model (5-year discounted cash flow, 6.7% rate, based on trailing figures to H1 2026) gives a base estimate of ₩5,193 per share, with a bear case of ₩0 and a bull case of ₩15,638. This is a model estimate based on the assumptions shown, not a target. The very wide range shows how sensitive the result is to cash flow assumptions, especially as free cash flow is currently negative.
Catalysts
- The half-year report for June 2026, filed 2026-08-14, is the latest full set of financial figures and shows trailing operating income of ₩84.0B.
- The 2026-05-13 filing on exercise of conversion right, preemptive right and exchange right may be relevant to the share count and capital structure, though details are not in the data.
- The March 2026 change of representative director and the annual general meeting results could matter for management direction.
- Retail investors were net buyers of about ₩509M over 20 days while foreigners were small net sellers, so flows could shift sentiment.
- The next quarterly filing will show whether the improvement in operating margin continues.
Risks
- Net margin is only 1.3% and net income fell to ₩2.1B in 2025, so profits are fragile.
- Liabilities are 199.7% of equity and borrowings of ₩97.0B exceed cash of ₩58.5B.
- Trailing free cash flow is negative at ₩19.5B, which weakens the cash flow basis for valuation.
- The model range runs from ₩0 to ₩15,638 per share, so any single estimate is highly uncertain.
- The share price is down 21.5% over one year and 12.2% over one month, with no news in the data to explain it.
Closing view
The data shows an operating recovery from a 2023 loss, with revenue and operating margin rising, alongside low multiples relative to both the company's history and most peers. Against that, net profits are thin, leverage is high and free cash flow is negative. The model's base estimate of ₩5,193 per share is well above the ₩1,024 close, but the bear case of ₩0 shows how dependent that estimate is on assumptions. The evidence is mixed and does not point clearly one way.
Model estimate of fair value
- Bear
- ₩0
- -100%
- Base
- ₩5,193
- +405%
- Bull
- ₩15,638
- +1421%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Base case of the 5-year discounted cash flow model on the stock's Valuation tab (statements TTM to H1 2026; discount rate 6.7%). Bear and Bull move the main assumptions by fixed steps. See and change the assumptions
Filings and data used
- Half-year report (Jun 2026)Aug 14, 2026
- Disclosure of Corporate Governance ReportMay 29, 2026
- Quarterly report (Mar 2026)May 15, 2026
- Exercise of Conversion Right, Preemptive Right for New Shares, and Exchange RightMay 13, 2026
- Annual general meeting resultsMar 26, 2026
- Change of Representative Director (Representative Executive Officer) (Informational Disclosure)Mar 26, 2026
- Audit report submittedMar 18, 2026
- Amended attachment: Annual report (Dec 2025)Mar 18, 2026
- Annual report (Dec 2025)Mar 18, 2026
- Amended: Change in revenue or profit of 30% or moreMar 11, 2026
- Reference Document for Proxy Solicitation of Voting RightsMar 11, 2026
- Notice of shareholders' meetingMar 11, 2026
- Daily prices up to 2026-10-23
- Financial statements, trailing 12 months as of H1 2026
- Our fair value model, statements as of TTM to H1 2026
Report history
Source: KRX statistical information